Subtype
Intracranial Neoplasm
CI-CAN-00001030Explore in graph →
Non-malignant522 active trials34 evidence items
- NCIt
- C4953
Loading cancer entity…
Subtype
CI-CAN-00001030Explore in graph →
Clinical trials
2,178 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05843253 | Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant | recruiting | Phase 2 | 120 | Nationwide Children's HospitalOTHER | 6 | May 29, 2026 | clinicaltrials |
| NCT07044557 | MeDex: No Perioperative Dexamethasone in Brain Metastases | recruiting | N/A | 35 | University of LouisvilleOTHER | 1 | May 29, 2026 | clinicaltrials |
| Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis: |
| recruiting |
| — |
| 500 |
| Xiangya Hospital of Central South UniversityOTHER |
| 1 |
| May 27, 2026 |
| clinicaltrials |
| NCT06974370 | Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial(ACTION-Brain) | recruiting | Phase 2 | 45 | University of Vermont Medical CenterOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT03184038 | Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery | recruiting | N/A | 90 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT04635657 | Cognitive Status After Removal of Skull Base Meningioma | recruiting | — | 50 | Ohio State UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT06807619 | A Study of Sotorasib in People With Brain Tumors | recruiting | Phase 1 | 16 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07411690 | Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors(CSF-IMR) | recruiting | — | 200 | Medical University of WarsawOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07479446 | Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery | recruiting | N/A | 174 | Xuanwu Hospital, BeijingOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT02754544 | Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors | recruiting | N/A | 75 | M.D. Anderson Cancer CenterOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT05342454 | A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain | recruiting | — | 1,720 | M.D. Anderson Cancer CenterOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT06048094 | 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery(FACILITATE) | recruiting | Phase 1 | 46 | Baptist Health South FloridaOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT07413796 | Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures(NEURO-SUTURE) | recruiting | N/A | 382 | Medical University of WarsawOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT05184790 | LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology(LEARN) | recruiting | — | 300 | University of SydneyOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT07418775 | Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma | recruiting | — | 3,000 | University of California, San FranciscoOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT06712927 | Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases | recruiting | Phase 2 | 60 | Stanford UniversityOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07594262 | NET-TIME: Inflammatory Tumor Microenvironment in Pituitary Neoplasm(NET-TIME) | recruiting | — | 60 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07589257 | A Study of VRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine Glioma | recruiting | Phase 2 | 10 | Guangzhou Virotech Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 15, 2026 | clinicaltrials |
| NCT06673329 | Brodalumab in the Treatment of Immune-Related Adverse Events | recruiting | Phase 1 | 11 | Brian Henick, MDOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT07003139 | A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors | recruiting | Phase 1 / Phase 2 | 10 | China Medical University HospitalOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT07584499 | Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors(MRG003) | recruiting | Phase 1 | 51 | Sun Yat-sen UniversityOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT05023434 | A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients With Brain Tumors | recruiting | N/A | 20 | Medical College of WisconsinOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT04699773 | LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138) | recruiting | N/A | 32 | University of Maryland, BaltimoreOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT05293197 | Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients(SONOKID) | recruiting | Phase 1 | 24 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT05553899 | Utility of PET-MRI in Surveillance of Paediatric Brain Tumours(PET-MRI) | recruiting | N/A | 5 | Sheffield Children's NHS Foundation TrustOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT07512154 | Precision Radiotherapy Enabled by Molecular MRI | recruiting | N/A | 20 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT07569042 | A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma | recruiting | Phase 1 / Phase 2 | 15 | Novelwise Pharmaceutical CorporationINDUSTRY | 1 | May 6, 2026 | clinicaltrials |
| NCT05629702 | ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids(ARISTOCRAT) | recruiting | Phase 2 | 120 | University of BirminghamOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07197632 | ioMRI in the Surgery of Brain Metastases.(MET-MRI) | recruiting | N/A | 154 | Technical University of MunichOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT06810336 | Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery | recruiting | Early Phase 1 | 40 | University of VirginiaOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT05545007 | Preoperative vs Postoperative Hypofractionated Radiosurgery for Patients With Large Brain Metastases(SUPPORT) | recruiting | N/A | 146 | Istituto Clinico HumanitasOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT06012695 | NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma | recruiting | Phase 1 / Phase 2 | 79 | Novelwise Pharmaceutical CorporationINDUSTRY | 1 | Apr 29, 2026 | clinicaltrials |
| NCT07017816 | A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.(JACOB) | recruiting | Early Phase 1 | 18 | Children's National Research InstituteOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT04222062 | A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease | recruiting | Phase 2 | 100 | University of NebraskaOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT06667726 | An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors | recruiting | Phase 2 | 47 | Mayo ClinicOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT04322734 | Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders | recruiting | — | 500 | Southwest Autism Research & Resource CenterOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT05233397 | ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | recruiting | Phase 2 | 30 | Nationwide Children's HospitalOTHER | 3 | Apr 23, 2026 | clinicaltrials |
| NCT05465174 | Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults(PNOC029) | recruiting | Phase 2 | 57 | Sabine Mueller, MD, PhDOTHER | 2 | Apr 23, 2026 | clinicaltrials |
| NCT04689048 | Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery | recruiting | Phase 1 | 20 | Baptist Health South FloridaOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT03684109 | Non-invasive Glioma Characterization Through Molecular Imaging | recruiting | N/A | 30 | University of MiamiOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07539792 | Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled Study(EEEA-AMSBP) | recruiting | Phase 2 | 126 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT05013892 | NTS-WBRT in Brain Metastases | recruiting | Phase 2 | 41 | Massachusetts General HospitalOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT05064280 | Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases | recruiting | Phase 2 | 104 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT07530536 | rTMS for Postoperative Brain Tumor Patients | recruiting | N/A | 6 | Brian J.GillOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT02800486 | Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA | recruiting | Phase 2 | 37 | Northwell HealthOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT04185038 | Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors | recruiting | Phase 1 | 90 | Seattle Children's HospitalOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT05222620 | SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial | recruiting | Phase 2 | 90 | Mayo ClinicOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06599879 | Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention(IPANEMA) | recruiting | N/A | 130 | Institut Claudius RegaudOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06810544 | Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss | recruiting | Phase 1 / Phase 2 | 191 | Tango Therapeutics, Inc.INDUSTRY | 1 | Apr 13, 2026 | clinicaltrials |
Data updated 23 days agoSource updated May 29, 2026source: clinicaltrials